MBBS, M Med(Ophth), FAMS
Specialty: Medical Retina, Cataract ＆ Comprehensive Ophthalmology
Sub-specialties: Medical Retina, Cataract ＆ Comprehensive Ophthalmology
Conditions Treated by this Doctor:
Age-related Macular Degeneration, Cataract Surgery, Diabetic Retinopathy, Retinal Vascular Disorders.
Dr Kelvin Teo has a strong interest in clinical research in the field of medical retina. In particular, his focus is on real world outcomes and how imaging techniques help to advance the pathophysiology and therapy of neovascular age related macular degeneration.
Real world outcomes for retina disease from registry data
Imaging for retina disease
Gene therapy for retina disease
Comparison of optical coherence tomography angiographic changes after anti-vascular endothelial growth factor therapy alone or in combination with photodynamic therapy in polypoidal choroidal vasculopathy Teo KYC, Yanagi Y, Lee SY, Yeo IYS, Tan GSW, Mathur R, Chan CM, Wong TY, Cheung CMG. Retina. 2017 Aug 1. doi: 10.1097/IAE.0000000000001776
Teo KY, Ng WY, Lee SY, Cheung GCM. Management of myopic choroidal neovascularization: Focus on Anti-VEGF therapy drugs, 2016, DOI 10.1007/s40265-016-0605-0
Iseato Y, Yuda K, Teo KY, Tan X, Murata T, Shindo T, Yanagi Y. Adrenomedullin: A potential therapeutic target for retinochorodial disease. Prog Retin Eye Res, 2016, May; 52:112-29. Doi:10.1016/j.preteyeres.2016.01.001. Epub 2016 Jan 12
Tan AC, Teo K, Guan OS, Koh A. Long-term outcomes of myopic choroidal neovascularisation treated with combined ranibizumab and dexamethasone characterised by multi-modal imaging. Graefes Arch Clin Exp Ophthalmol. 2016 Mar [Epub ahead of print] PubMed PMID: 26968717
Chan NS, Teo K, Cheung CM. Epidemiology and diagnosis of myopic choroidal neovascularization in Asia eye contact lens. 2016 Jan;42(1):48-55. doi: 10.1097/ICL.0000000000000201. PubMed PMID: 26448447
Subscribe to our mailing list to get the updates to your inbox